Ideas
US ban on Chinese robots benefits Korea.
The US ban on Chinese humanoid robots is highly beneficial for Korean robot manufacturers, as it prevents them from being squeezed between US software and Chinese hardware.
Defensive rotation targets after excessive price declines.
Liquor stocks like HiteJinro and Lotte Chilsung are benefiting from a defensive rotation in a weak market. HiteJinro, in particular, has fallen so much that it appears to have bottomed out.
Sovereign AI positioning and shareholder returns attract.
NAVER's value will shine when the market normalizes. The confirmation of Nvidia's investment, combined with share cancellations and its solid positioning in Sovereign AI as Korea's dominant portal, makes it highly attractive.
Strong Q2 earnings and improving product mix.
In a high-interest-rate environment where the broader biotech sector struggles, CDMO/CMO and biosimilar companies with actual earnings growth, like Celltrion and Yuhan, will survive and stand out.
Raised capex guidance confirms AI infrastructure commitment.
Meta's EPS missed due to one-off costs, but revenue beat expectations and the bottom end of its capex guidance was raised. This confirms the company's strong, ongoing commitment to AI infrastructure investment.
Strong Azure growth proves AI monetization.
Microsoft's Q2 earnings beat expectations, driven by 43% growth in Azure and an 84% YoY surge in Remaining Performance Obligations (RPO). This proves that AI investments are generating tangible returns and high revenue visibility.
Bill Gates' visit boosts domestic SMR stocks.
Bill Gates is visiting Korea to discuss SMR supply chains with SK and HD Hyundai. This upcoming event could provide momentum for domestic nuclear equipment and SMR-related companies once the broader market stabilizes.
AI fundamentals remain strong; accumulate on dips.
Fears of an AI bubble are unfounded, as big tech data center revenues continue to surge. The recent market plunge has brought Samsung Electronics and SK Hynix down to technical rebound zones, making it a good time to accumulate on dips.
Strong uptrends despite market weakness offer opportunities.
Cosmetics companies are showing strong uptrends and approaching new highs despite the broader market weakness. They offer solid short-term trading opportunities in the current volatile environment.
Improving lead frame profitability drove earnings beat.
Despite deficits in package substrates, Haesung DS's lead frame profitability is improving, which drove a Q2 earnings beat. Industry conditions remain very favorable.
Growing in Western markets, reducing China reliance.
Amorepacific and LG H&H are successfully reducing their dependence on China while growing in North America and Europe. Amorepacific has shifted to functional and reasonable pricing, and LG H&H recently received its first analyst upgrades in four years.
Higher China utilization and US nearing break-even.
Cosmax is preferred over Kolmar Korea because Cosmax has higher utilization rates in China and its US subsidiary is nearing the break-even point, whereas Kolmar is still absorbing fixed costs from early-stage investments.
Earnings-backed CDMO and biosimilar companies will outperform.
In a high-interest-rate environment where the broader biotech sector struggles, CDMO/CMO and biosimilar companies with actual earnings growth, like Celltrion and Yuhan, will survive and stand out.
This 815 Money Talk (815머니톡) video, published July 30, 2026,
features Lee Ju-hyeon, Lee Kwon-hee, Kim Tae-seong
discussing 058610.KQ, 272830.KQ, 000080.KS, 005300.KS, 035420.KS, 068270.KS, META, MSFT, 329180.KS, 096770.KS, 034020.KS, 000660.KS, 005930.KS, 026220.KS, 214450.KQ, 241710.KQ, 195870.KS, 090430.KS, 051900.KS, 192820.KS, 000100.KS.
13 trade ideas extracted by AI with direction and confidence scoring.
Speakers:
Lee Ju-hyeon,
Lee Kwon-hee,
Kim Tae-seong
· Tickers:
058610.KQ,
272830.KQ,
000080.KS,
005300.KS,
035420.KS,
068270.KS,
META,
MSFT,
329180.KS,
096770.KS,
034020.KS,
000660.KS,
005930.KS,
026220.KS,
214450.KQ,
241710.KQ,
195870.KS,
090430.KS,
051900.KS,
192820.KS,
000100.KS